封面
市場調查報告書
商品編碼
1630964

被忽視的熱帶疾病診斷市場規模、佔有率、趨勢分析報告:按疾病、診斷方法、服務類型、最終用途、地區、細分市場預測,2025-2030年

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya, Rabies, Leprosy), By Diagnostic Method, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

被忽視的熱帶疾病診斷市場成長與趨勢:

Grand View Research, Inc. 的最新報告顯示,到 2030 年,全球被忽視的熱帶疾病診斷市場預計將達到 95.9 億美元。

預計2025年至2030年該市場將以7.73%的複合年成長率成長。疾病負擔的增加、疾病早期檢測需求的增加以及技術的互補進步預計將推動需求成長。

人們對被忽視的熱帶疾病及其對人口和經濟的影響越來越感興趣,這推動了對早期疾病檢測方法開發的需求。這種日益成長的興趣體現在許多旨在對抗被忽視熱帶疾病的計畫的推出上。例如,被忽視的熱帶疾病全球網路旨在意識提升並資金籌措,以控制和消除最常見的被忽視的熱帶疾病。此外,多家公司正在努力開發更複雜、更便宜的熱帶疾病診斷方法。 2021 年 1 月,諾華公司與世界衛生組織簽署協議,在全球範圍內管理痲瘋病。預計這將在整個預測期內支持該市場的成長。

據世界衛生組織稱,截至 2022 年 1 月,全球有超過 15 億人感染土源性感染疾病感染。 Kato-Katz 技術是 WHO 的黃金標準,廣泛用於診斷 STH 的強度。這些感染疾病廣泛分佈於熱帶和亞熱帶地區,在美洲、撒哈拉以南非洲、東亞和中國多發。此外,主要企業的存在預計將推動整體市場的成長。這些公司參與新產品開發被認為有助於 NTD 診斷市場的發展。

被忽視的熱帶疾病診斷市場的報告要點

  • 按疾病類型分類,由於盛行率不斷上升以及診斷測試的採用率較高,土傳蠕蟲病將在 2024 年佔據市場主導地位。
  • 2024 年的市場規模絕大多數是分子/現代診斷領域。這是由於分子診斷技術的研發加速以及對照護現場產品的需求增加。
  • 就 2024 年的市場佔有率而言,集中式服務因其高技能水平以及基礎設施和人力的廣泛輔助支援而佔據最大部分。
  • 從最終用途來看,由於 POCT 服務的日益普及和需求,家庭醫療保健預計將成長最快。
  • 由於 NTD 疾病負擔高、醫療保健支出不斷增加、技術進步迅速以及客戶對使用 PCR 檢測診斷 NTD 的意識不斷增強,亞太地區將在 2024 年佔據全球市場的主導地位。
  • 由於 IVD 產品的滲透率不斷提高以及發展中國家被忽視的熱帶疾病的高疾病負擔,預計拉丁美洲未來將顯著成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章被忽視的熱帶疾病診斷市場變數、趨勢和範圍

  • 市場體系展望
    • 相關/附隨市場展望
  • 滲透率和成長前景圖
  • 使用者觀點分析
    • 消費行為分析
    • 市場影響者分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
  • 被忽視的熱帶疾病診斷:市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 被忽視的熱帶疾病診斷市場:按疾病細分分析,2018-2030 年(百萬美元)

  • 定義和範圍
  • 2024 年及 2030 年疾病市場佔有率分析
  • 全球被忽視的熱帶疾病診斷市場(按疾病),2018-2030
  • 2018-2030年市場規模/預測與趨勢分析

第5章被忽視的熱帶疾病診斷市場:按診斷方法細分分析,2018-2030 年(百萬美元)

  • 定義和範圍
  • 2024 年和 2030 年診斷方法市場佔有率分析
  • 全球被忽視的熱帶疾病診斷市場(依診斷方法),2018-2030
  • 2018-2030年市場規模/預測與趨勢分析

第6章被忽視的熱帶疾病診斷市場:細分分析,按服務類型,2018-2030(百萬美元)

  • 定義和範圍
  • 2024/2030 年服務類型市場佔有率分析
  • 全球被忽視的熱帶疾病診斷市場,依服務類型,2018-2030
  • 2018-2030年市場規模/預測與趨勢分析

第 7 章 被忽視的熱帶疾病診斷市場:2018-2030 年按最終用途分類的細分分析(百萬美元)

  • 定義和範圍
  • 2024 年及 2030 年最終用途市場佔有率分析
  • 全球被忽視的熱帶疾病診斷市場(依最終用途),2018-2030 年
  • 2018-2030年市場規模/預測與趨勢分析

第8章被忽視的熱帶疾病診斷市場:區域市場分析,2018-2030(百萬美元)

  • 定義和範圍
  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場:主要企業
  • 2018-2030年市場規模、預測、趨勢分析:
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章被忽視的熱帶疾病診斷市場-競爭分析

  • 公司/競爭對手分類(主要創新者、市場領導、新興企業)
  • 供應商情況
    • 主要經銷商及通路夥伴名單
  • 主要企業簡介
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • Oscar Medicare Pvt Ltd
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends:

The global neglected tropical diseases diagnosis market size is anticipated to reach USD 9.59 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 7.73% from 2025 to 2030. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Diseases Diagnosis Market Report Highlights:

  • By disease type, the soil-transmitted helminthiases dominated the market in 2024, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2024, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2024 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2024, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Information procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third-party perspectives
    • 1.2.4. Primary research
  • 1.3. Information analysis
    • 1.3.1. Data analysis models
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neglected Tropical Diseases Diagnosis Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. User perspective analysis
    • 3.3.1. Consumer Behavior Analysis
    • 3.3.2. Market Influencer Analysis
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
  • 3.5. Neglected Tropical Diseases Diagnosis: Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat from new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political Landscape
      • 3.5.2.2. Environmental Landscape
      • 3.5.2.3. Social Landscape
      • 3.5.2.4. Technology Landscape
      • 3.5.2.5. Legal Landscape

Chapter 4. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Disease, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Disease market share analysis, 2024 & 2030
  • 4.3. Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Dengue
    • 4.4.2. Chikungunya
    • 4.4.3. Rabies
    • 4.4.4. Leprosy
    • 4.4.5. Buruli ulcer
    • 4.4.6. Yaws
    • 4.4.7. Lymphatic Filariasis
    • 4.4.8. Taeniasis/Cysticercosis
    • 4.4.9. Foodborne trematode infections
    • 4.4.10. Echinococcosis
    • 4.4.11. Chagas disease
    • 4.4.12. Dracunculiasis
    • 4.4.13. Human African trypanosomiasis (sleeping sickness)
    • 4.4.14. Soil-transmitted helminthiases
    • 4.4.15. Onchocerciasis
    • 4.4.16. Schistosomiasis
    • 4.4.17. Scabies and other ectoparasites
    • 4.4.18. Snakebite Envenoming
    • 4.4.19. Leishmaniases

Chapter 5. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Diagnostic Method, 2018-2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Diagnostic method market share analysis, 2024 & 2030
  • 5.3. Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic method, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Conventional Method
    • 5.4.2. Molecular/Modern Method

Chapter 6. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By Service Type, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Service type market share analysis, 2024 & 2030
  • 6.3. Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Centralized Service
    • 6.4.2. POC Service

Chapter 7. Neglected Tropical Diseases Diagnosis Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definitions & Scope
  • 7.2. End use market share analysis, 2024 & 2030
  • 7.3. Global Neglected Tropical Diseases Diagnosis Market, By End Use, 2018 to 2030
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Clinical Labs
    • 7.4.2. Hospitals /Clinics
    • 7.4.3. Home Healthcare

Chapter 8. Neglected Tropical Diseases Diagnosis Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1. Definitions & Scope
  • 8.2. Regional market share analysis, 2024 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market: Key Players
  • 8.5. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 8.6. North America
    • 8.6.1. North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.2. U.S.
      • 8.6.2.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.3. Canada
      • 8.6.3.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.7. Europe
    • 8.7.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2. Germany
      • 8.7.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3. UK
      • 8.7.3.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.8. Asia Pacific
    • 8.8.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.2. China
      • 8.8.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.3. Indonesia
      • 8.8.3.1. Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.4. India
      • 8.8.4.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.8.5. Malaysia
      • 8.8.5.1. Malaysia market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.9. Latin America
    • 8.9.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.2. Brazil
      • 8.9.2.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.3. Colombia
      • 8.9.3.1. Colombia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.9.4. Venezuela
      • 8.9.4.1. Venezuela market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.10. Middle East and Africa
    • 8.10.1. Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.10.2. Nigeria
      • 8.10.2.1. Nigeria market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Neglected Tropical Diseases Diagnosis Market - Competitive Analysis

  • 9.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
  • 9.3. Key companies profiled
    • 9.3.1. F. Hoffmann-La Roche Ltd
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Abbott
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Thermo Fisher Scientific Inc.
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. ZeptoMetrix
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. InBios International, Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Genome Diagnostics Pvt. Ltd.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Omega Diagnostics Group PLC
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Coris BioConcept
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. DiaSys Diagnostic Systems GmbH
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Oscar Medicare Pvt Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 5 North America Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 7 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 10 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 12 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 13 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 15 Europe Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 17 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 19 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 20 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 21 UK Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 22 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 23 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 25 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 29 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 30 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 31 Indonesia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 32 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 33 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 34 China Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 35 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 36 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 37 India Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 38 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 39 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 40 Malaysia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 41 Latin America Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 42 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Latin America Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 45 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 48 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 49 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 50 Colombia Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 51 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 52 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 53 Venezuela Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)
  • Table 58 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 Nigeria Neglected Tropical Diseases Diagnosis Market, By End use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis
  • Fig. 16 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis
  • Fig. 17 Neglected tropical diseases diagnosis market: Service type movement analysis
  • Fig. 18 Neglected tropical diseases diagnosis market: End use movement analysis
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 Regional outlook, 2024 & 2030
  • Fig. 21 North America Neglected Tropical Diseases Diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 24 Europe neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 25 UK neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Asia Pacific neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 28 Indonesia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 29 China neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 30 India neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 31 Malaysia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 32 Latin America neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 33 Brazil neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 34 Colombia neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 35 Venezuela neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 36 MEA neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 37 Nigeria neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)